National Edu News: AstroSat’s Ultraviolet Imaging Telescope spots rare ultraviolet-bright stars  |  Parent Interventions: Randomized trials could help to return children safely to schools   |  Parent Interventions: How fellow students improve your own grades   |  Parent Interventions: School-made lunch 'better' for children  |  Teacher Insights: Second Anniversary of India Science, Nation’s OTT Channel  |  Leadership Instincts: Participation of MGIEP in the Implementation of NEP 2020  |  Teacher Insights: World of Puzzling Patterns  |  Education Information: HKUST Collaborates with Hang Lung to Foster Young Mathematics Talent  |  Leadership Instincts: Global Environment Outlook 6 Chinese version launched  |  Leadership Instincts: Peking University academics visits Beijing Representative Office of World Bank  |  Teacher Insights: U of T prof uses virtual reality to beam engineering lab into students' homes   |  Science Innovations: AI algorithm that can detect leaks instantly in gas pipeline networks  |  Parent Interventions: Smacking young children has long-lasting effects  |  Technology Inceptions: NUS engineers create ‘smart’ aerogel that turns air into drinking water  |  International Edu News: Free online tool calculates risk of COVID transmission in low ventilated spaces  |  
April 03, 2020 Friday 06:17:51 PM IST

University of Pittsburgh Covid-19 Vaccine Undergoes Animal Trials Successfully

Image by Gerd Altman for Pixabay

The University of Pittsburgh School of Medicine have announced the development of a potential vaccine agaisnt SARS-CoV 2, the new coronavirus that is causing the pandemic. It was tested in mice through a fingertip-sized patch. The results were promising as it produced antibodies specific to SARS-CoV-2 thought to be sufficient for neutralizing the virus. 
A novel approach was used to deliver the vaccine through a microneedle array to increase the poteny. This array is a fingertip-sized patch of 400 tiny needles that delivers the spike protein pieces into the skin, where the immune reaction is strongest. The patch goes on like a Band-Aid and then the needles—which are made entirely of sugar and the protein pieces—simply dissolve into the skin.
The system is also highly scalable. The protein pieces are manufactured by a “cell factory”—layers upon layers of cultured cells engineered to express the SARS-CoV-2 spike protein—that can be stacked further to multiply yield. Purifying the protein can also be done at industrial scale. Mass-producing the microneedle array involves spinning down the protein-sugar mixture into a mold using a centrifuge. Once manufactured, the vaccine can sit at room temperature until it’s needed, eliminating the need for refrigeration during transport or storage. 
The researchers have previous experience in working on SARS-Cov 2003 and MERS-Cov 2014. Scientists from diverse areas of research collaborated to make the vaccine. It followed a more established approach using lab-made pieces of viral protein to build immunity. It is similar to the way flu shots work.
More Details: https://www.pittwire.pitt.edu/news/covid-19-vaccine-candidate-shows-promise-first-peer-reviewed-research



Comments